| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/04/2001 | CA2334382A1 Method for producing cloned cows |
| 01/03/2001 | EP1065215A1 Homomeric and heteromeric AMPA receptors |
| 01/03/2001 | EP1065212A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 01/03/2001 | EP1064932A1 Use of dedifferentiated plant cells |
| 01/03/2001 | EP1064551A1 Development of human monoclonal antibodies and uses thereof |
| 01/03/2001 | EP1064545A1 CO-EXPRESSION OF Gia PROTEIN AND Gi PROTEIN COUPLED RECEPTOR TO ENHANCE SIGNAL TRANSDUCTION RESPONSES |
| 01/03/2001 | EP1064393A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 01/03/2001 | EP1064388A1 Human casb12 polypeptide, a serine protease |
| 01/03/2001 | EP1064387A2 $i(LIMANTHES) OIL GENES |
| 01/03/2001 | EP1064383A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064381A1 Cardiostatin polypeptides and polynucleotides |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064379A2 Human nucleic acid sequences from tissue of breast tumors |
| 01/03/2001 | EP1064378A2 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/03/2001 | EP1064377A1 Casb414: antigen overexpressed in several tumours |
| 01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
| 01/03/2001 | EP1064373A2 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins |
| 01/03/2001 | EP1064372A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/03/2001 | EP1064371A2 Isolated mammalian membrane protein genes and related reagents |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064368A1 Suppressors of cytokine signalling |
| 01/03/2001 | EP1064367A2 Production of biofilaments in transgenic animals |
| 01/03/2001 | EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES |
| 01/03/2001 | EP1064365A2 Expression of trehalose biosynthetic genes in plants |
| 01/03/2001 | EP1064364A1 The cytokine family member 2-21 |
| 01/03/2001 | EP1064363A1 Retroviral packaging cell line |
| 01/03/2001 | EP1064362A1 Nek1-related protein kinase |
| 01/03/2001 | EP1064360A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 01/03/2001 | EP1064357A1 Processes for improved presentation of antigens by dendritic cells |
| 01/03/2001 | EP1064356A2 Cardiac-derived stem cells |
| 01/03/2001 | EP1064355A2 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
| 01/03/2001 | EP1064354A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 01/03/2001 | EP1064309A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 01/03/2001 | EP1064307A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 01/03/2001 | EP1064304A2 Genes encoding mlo proteins and conferring fungal resistance upon plants |
| 01/03/2001 | EP1064301A1 Bacterial yael family members as targets for antimicrobial drug design |
| 01/03/2001 | EP1064297A1 95 human secreted proteins |
| 01/03/2001 | EP1064296A1 Thermostable dna polymerase from thermoanaerobacter thermohydrosulfuricus |
| 01/03/2001 | EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 01/03/2001 | EP1064064A1 Removal of contaminants from biological products |
| 01/03/2001 | EP1064027A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 01/03/2001 | EP1064016A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 01/03/2001 | EP1064007A1 nrdG |
| 01/03/2001 | EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 01/03/2001 | EP1063891A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
| 01/03/2001 | EP1063887A1 P53-dependent secretion of growth inhibitory factors |
| 01/03/2001 | EP1063882A1 Skin equivalent and methods of forming and using same |
| 01/03/2001 | EP0727046B1 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease |
| 01/03/2001 | CN1278866A MPL ligand analogs |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1060216C Improved methods for the preparation of endotoxinbinding proteins |
| 01/02/2001 | US6169226 Starch branching enzyme II of potato |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169070 Mer receptor activation by gas6 |
| 01/02/2001 | US6169068 Treating lung disease or disorder by inhalating a protein |
| 01/02/2001 | US6168953 Increasing efficiency of viricide in host cell by contacting with vector derived from spumavirinae, spumavirus, lentivirinae, or lentivirus; vector contains a cis-acting genetic element which colocalizes the viricide with target |
| 01/02/2001 | US6168942 Attenuated forms of bovine viral diarrhea virus |
| 01/02/2001 | US6168941 Preparing viral plasmid cultures; culturing cells, perfusing cultures with fresh nutrients, incubate and infect cells with plasmids, replicate and recover plasmids |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168926 Screening for modulators of preferential enzyme activity; incubating cells with modulators and detecting expression of reporter molecules, amplification of expression indicates an inhibitor, decreased expression indicates an activator |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168916 Host adaptation of retroviral vectors |
| 01/02/2001 | US6168915 Mixed cell diagnostic systems |
| 01/02/2001 | US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv |
| 01/02/2001 | CA2312526A1 Use of dedifferentiated plant cells |
| 01/02/2001 | CA2311168A1 Functional genomic screen for post-transcriptional 5' and 3' regulatory elements |
| 01/02/2001 | CA2214280C Cryopreservation solution |
| 01/02/2001 | CA2113203C Human calcium channel compositions and methods |
| 01/02/2001 | CA2035899C Chimeric anti-cea antibody |
| 12/29/2000 | CA2300467A1 Cancer vaccines |
| 12/28/2000 | WO2000079010A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 12/28/2000 | WO2000079002A1 Means for identifying the locus of a major resistance gene with respect to the virus of the rice yellow mottle virus and uses thereof |
| 12/28/2000 | WO2000078986A1 Regulation system of expression using nuclear ppar receptors |
| 12/28/2000 | WO2000078985A1 Plant multi-gene expression constructs |
| 12/28/2000 | WO2000078981A1 Method of increasing the resistance of cultivated plants to phytopathogenic fungi and bacteria by methods of molecular genetics |
| 12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/28/2000 | WO2000078979A1 Method for increasing the resistance of cultivated plants to chemical stress |
| 12/28/2000 | WO2000078975A2 Rice sucrose synthase promoter |
| 12/28/2000 | WO2000078973A1 Process for oxidising aromatic compounds |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078931A2 Neuronal cell material, use of said material as a transplant and method for producing the same |
| 12/28/2000 | WO2000078930A1 Method for enhancing hematopoiesis |
| 12/28/2000 | WO2000078929A1 Methods of making pancreatic islet cells |
| 12/28/2000 | WO2000078928A2 Surface for cell culture |
| 12/28/2000 | WO2000078927A2 Spheroid preparation |
| 12/28/2000 | WO2000078920A1 Methods and devices for cell culturing and organ assist systems |
| 12/28/2000 | WO2000078814A2 LO-CD2b ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 12/28/2000 | WO2000078813A2 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
| 12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
| 12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
| 12/28/2000 | WO2000078348A1 Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells |